Arkolith/Insider Trading/EMMA/Form 4

Niihara Yutaka

Chairman and CEO, Director, 10% OwnerEmmaus Life Sciences, Inc. (EMMA) · full profile →Form 4 · filed Dec 1, 2022
Net Buying
Open-Market Buys
$21K
Open-Market Sells
$0
Net Open-Market Flow
$21K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 30, 2022Buy(P)23K$0.41$9K12.0M
Nov 29, 2022Buy(P)15K$0.38$6K12.0M
Nov 28, 2022Buy(P)5K$0.35$2K12.0M
Nov 4, 2022Buy(P)8K$0.45$3K12.0M
Nov 3, 2022Buy(P)3K$0.45$1K12.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-059154) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML